α2-Adrenoreceptors Profile Modulation. 3. (R)-(+)-m-Nitrobiphenyline, a New Efficient and α2C-Subtype Selective Agonist
摘要:
To assess the stereochemical requirements for efficient (alpha(2C)-adrenoreceptor activation, the enantiomeric forms of m-nitrobiphenyline [(+/-)-5] were prepared and tested on cells expressing the human alpha(2)-adrenoreceptor subtypes. The importance of chirality was confirmed, since the enantiomer (R)-(+)-5 was much more efficient than (S)-(-)-5 in producing (alpha(2C)-activation. Surprising reversal of enantioselectivity was observed with respect to structurally similar biphenyline [(+/-)-l] whose (S)-(-)-form proved the preferred (alpha(2C)-configuration.
α2-Adrenoreceptors Profile Modulation. 3. (R)-(+)-m-Nitrobiphenyline, a New Efficient and α2C-Subtype Selective Agonist
摘要:
To assess the stereochemical requirements for efficient (alpha(2C)-adrenoreceptor activation, the enantiomeric forms of m-nitrobiphenyline [(+/-)-5] were prepared and tested on cells expressing the human alpha(2)-adrenoreceptor subtypes. The importance of chirality was confirmed, since the enantiomer (R)-(+)-5 was much more efficient than (S)-(-)-5 in producing (alpha(2C)-activation. Surprising reversal of enantioselectivity was observed with respect to structurally similar biphenyline [(+/-)-l] whose (S)-(-)-form proved the preferred (alpha(2C)-configuration.
Fruitful Adrenergic α<sub>2C</sub>-Agonism/α<sub>2A</sub>-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence<sup>,</sup>
作者:Fabio Del Bello、Laura Mattioli、Francesca Ghelfi、Mario Giannella、Alessandro Piergentili、Wilma Quaglia、Claudia Cardinaletti、Marina Perfumi、Russell J. Thomas、Ugo Zanelli、Carla Marchioro、Michele Dal Cin、Maria Pigini
DOI:10.1021/jm100977d
日期:2010.11.11
The functional in vitro study of the enantiomers of imidazolines 4-7 highlighted the role played by the nature of the ortho phenyl substituent in determining the preferred alpha(2C)-AR configuration. Indeed, the (S) enantiomers of 4-6 or (R) enantiomer of 7 behave as eutomers and activate this subtype as full agonists; the corresponding distomers are partial agonists. Because in clinical pain management with opioids alpha(2C)-AR agonists, devoid of the alpha(2A)-AR-mediated side effects, may represent an improvement over current therapies with clonidine like drugs, 4 and its enantiomers, showing alpha(2C)-agonism/alpha(2A)-Aantagonism, have been studied in vivo. The data suggest that partial alpha(2C)-activation is compatible with effective enhancement of morphine analgesia and reduction both of morphine tolerance acquisition and morphine dependence acquisition and expression. On the contrary, full alpha(2C)-activation appears advantageous in reducing morphine tolerance expression. Interestingly, the biological profile displayed by 4 (allyphenyline) and its eutomer (S)-(+)-4 has been found to be very unusual.
α<sub>2</sub>-Adrenoreceptors Profile Modulation. 3. (<i>R</i>)-(+)-<i>m</i>-Nitrobiphenyline, a New Efficient and α<sub>2C</sub>-Subtype Selective Agonist
To assess the stereochemical requirements for efficient (alpha(2C)-adrenoreceptor activation, the enantiomeric forms of m-nitrobiphenyline [(+/-)-5] were prepared and tested on cells expressing the human alpha(2)-adrenoreceptor subtypes. The importance of chirality was confirmed, since the enantiomer (R)-(+)-5 was much more efficient than (S)-(-)-5 in producing (alpha(2C)-activation. Surprising reversal of enantioselectivity was observed with respect to structurally similar biphenyline [(+/-)-l] whose (S)-(-)-form proved the preferred (alpha(2C)-configuration.